National trends and feasibility of a robotic surgical approach in the management of patients with inflammatory bowel disease

被引:5
|
作者
Radomski, Shannon N. [1 ]
Stem, Miloslawa [1 ]
Consul, Michael [1 ]
Maturi, Jay Rammohan [1 ]
Chung, Haniee [1 ]
Gearhart, Susan [1 ]
Graham, Ada [1 ,2 ]
Obias, Vincent J. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Colorectal Res Unit, Baltimore, MD 21205 USA
[2] Johns Hopkins Med, Natl Capital Reg, 10215 Fernwood Rd,Suite 630, Bethesda, MD 20817 USA
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2023年 / 37卷 / 10期
关键词
Robotic surgery; Crohn's disease; Ulcerative colitis; Inflammatory bowel disease; MINIMALLY INVASIVE SURGERY; PROCTECTOMY; PREVALENCE; OUTCOMES;
D O I
10.1007/s00464-023-10333-1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Research on the utilization of robotic surgical approaches in the management of inflammatory bowel disease (IBD) is limited. The aims of this study were to identify temporal trends in robotic utilization and compare the safety of a robotic to laparoscopic operative approach in patients with IBD.Methods Patients who underwent minimally invasive surgery (MIS) for IBD were identified using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database (2013-2021). Temporal trends of robotic utilization were assessed from 2013 to 2021. Primary (30-day overall and serious morbidity) and secondary (unplanned conversion to open) outcomes were assessed between 2019 and 2021, when robotic utilization was highest. Multivariable logistic regression was performed.Results The use of a robotic approach for colectomies and proctectomies increased significantly between 2013 and 2021 (p < 0.001), regardless of disease type. A total of 6016 patients underwent MIS for IBD between 2019 and 2021. 2234 (37%) patients had surgery for UC [robotic 430 (19.3%), lap 1804 (80%)] and 3782 (63%) had surgery for CD [robotic 500 (13.2%), lap 3282 (86.8%)]. For patients with UC, there was no difference in rates of overall morbidity (22.6% vs. 20.7%, p = 0.39), serious morbidity (11.4% vs. 12.3%, p = 0.60) or conversion to open (1.5% vs. 2.1%, p = 0.38) between the laparoscopic and robotic approaches, respectively. There was no difference in overall morbidity between the two groups in patients with CD (lap 14.0% vs robotic 16.4%, p = 0.15), however the robotic group exhibited higher rates of serious morbidity (7.3% vs. 11.2%, p < 0.01), shorter LOS (3 vs. 4 days, p < 0.001) and lower rates of conversion to an open procedure (3.8% vs. 1.6%, p = 0.02). Adjusted analysis showed similar results.Conclusion The use of the robotic platform in the surgical management of IBD is increasing and is not associated with an increase in 30-day overall morbidity compared to a laparoscopic approach.
引用
收藏
页码:7849 / 7858
页数:10
相关论文
共 50 条
  • [41] Towards Equitable Surgical Management of Inflammatory Bowel Disease: A Systematic Review of Disparities in Surgery for Inflammatory Bowel Disease
    Booth, Alexander
    Ford, Wilson
    Brennan, Emily
    Magwood, Gayenell
    Forster, Erin
    Curran, Thomas
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (09) : 1405 - 1419
  • [42] Characterization of inflammatory bowel disease in Colombia: Results of a national register
    Juliao-Banos, F.
    Puentes, F.
    Lopez, R.
    Saffon, M. A.
    Reyes, G.
    Parra, V.
    Galiano, M. T.
    Barraza, M.
    Molano, J.
    Alvarez, E.
    Corrales, R.
    Vargas, L. E.
    Gil, F.
    Alvarez, P.
    Limas, L.
    Prieto, R.
    Yance, P.
    Diaz, F.
    Bareno, J.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2021, 86 (02): : 153 - 162
  • [43] Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus
    Amiot, Aurelien
    Bouguen, Guillaume
    Bonnaud, Guillaume
    Bouhnik, Yoram
    Hagege, Herve
    Peyrin-Biroulet, Laurent
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (01) : 35 - 43
  • [44] Current evaluation and management of anemia in patients with inflammatory bowel disease
    Martin, Julia
    Radeke, Heinfried H.
    Dignass, Axel
    Stein, Juergen
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (01) : 19 - 32
  • [45] Results of the national registry of patients diagnosed with inflammatory bowel disease candidates for bariatric surgery (ReNacEIBar)
    Ferrer-Marquez, Manuel
    Bernal, Ma Dolores Frutos
    de Gordejuela, Amador Garcia Ruiz
    Garcia-Redondo, Manuel
    Millan, Menica
    Pereferrer, Fatima Sabench
    Palomares, Jordi Tarasce
    CIRUGIA ESPANOLA, 2024, 102 (01): : 44 - 52
  • [46] Short-term outcomes of bariatric surgery in patients with inflammatory bowel disease: a national analysis
    Mabeza, Russyan Mark
    Vadlakonda, Amulya
    Chervu, Nikhil
    Ebrahimian, Shayan
    Sakowitz, Sara
    Yetasook, Amy
    Benharash, Peyman
    SURGERY FOR OBESITY AND RELATED DISEASES, 2024, 20 (02)
  • [47] Quality of Care in Patients With Inflammatory Bowel Disease
    Jackson, Belinda D.
    De Cruz, Peter
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (03) : 479 - 489
  • [48] Insights into the role of cannabis in the management of inflammatory bowel disease
    Picardo, Sherman
    Kaplan, Gitaad G.
    Sharkey, Keith A.
    Seow, Cynthia H.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [49] Hearing Loss in Patients with Inflammatory Bowel Disease
    Wengrower, Dov
    Koslowsky, Benjamin
    Peleg, Uri
    Mazuz, Betty
    Cohen, Leore
    Ben-David, Allin
    Gross, Menahem
    Goldin, Eran
    Shaul, Chanan
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (07) : 2027 - 2032
  • [50] Challenges in the Medical and Surgical Management of Chronic Inflammatory Bowel Disease
    Bailey, Ellen H.
    Glasgow, Sean C.
    SURGICAL CLINICS OF NORTH AMERICA, 2015, 95 (06) : 1233 - +